From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML
Bone Marrow Transplant
.
2015 Oct;50(10):1382-4.
doi: 10.1038/bmt.2015.155.
Epub 2015 Jul 6.
Authors
M Krumbholz
1
,
J Bradtke
2
,
D Stachel
1
,
O Peters
3
,
B Hero
4
,
W Holter
1
,
R Slany
5
,
M Metzler
1
Affiliations
1
Department of Paediatric Oncology, University Hospital Erlangen, Erlangen, Germany.
2
Oncogenetic Laboratory, Molecular Pathology, Institute of Pathology, University Hospital Giessen and Marburg, Giessen, Germany.
3
Department of Paediatics, St. Hedwig Hospital, Regensburg, Germany.
4
Department of Paediatric Oncology, University of Cologne, Cologne, Germany.
5
Department of Genetics, University of Erlangen, Erlangen, Germany.
PMID:
26146805
DOI:
10.1038/bmt.2015.155
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Child, Preschool
Female
Humans
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / therapy*